Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates that USP1-stabilized RPS16 promotes growth and metastasis in hepatocellular carcinoma cells, suggesting a novel therapeutic target.
These findings reveal a previously unrecognized role for the activation of USP1-RPS16 pathway in driving HCC, which may be further developed as a novel strategy for cancer treatment.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: